Drugs Approved for Head and Neck Cancer - National Cancer Institute

Drugs Approved for Head and Neck Cancer - National Cancer Institute

Drugs Approved for Head and Neck Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx [voice box]). The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in head and neck cancer that are not listed here.

ON THIS PAGE

• Drugs Approved for Head and Neck Cancer
• Drug Combinations Used in Head and Neck Cancer

Drugs Approved for Head and Neck Cancer

• Bleomycin Sulfate
• Cetuximab
• Docetaxel
• Erbitux (Cetuximab)
• Hydrea (Hydroxyurea)
• Hydroxyurea
• Keytruda (Pembrolizumab)
• Methotrexate
• Nivolumab
• Opdivo (Nivolumab)
• Pembrolizumab
• Taxotere (Docetaxel)
• Trexall (Methotrexate)

Drug Combinations Used in Head and Neck Cancer

• TPF

Related Resources

• Head and Neck Cancer—Patient Version
• Chemotherapy and You: Support for People With Cancer

• Updated: May 16, 2019